STAT+: New immunotherapy combination could ‘change the landscape’ of cancer treatment
A pair of new studies suggest that combining two different kinds of inhibitors could be a new effective approach to immunotherapy.
When they work, immunotherapy drugs called checkpoint inhibitors can shrink cancers and, in some cases, eradicate tumors altogether. These drugs, which include
